上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
Atazanavir (Synonyms: 阿扎那韦; BMS-232632) 纯度: 99.23%
Atazanavir (BMS-232632) 是一种高选择性的 HIV-1蛋白酶抑制剂，用于艾滋病毒感染的研究。Atazanavir 是 CYP3A4 的底物和抑制剂，也是 P-糖蛋白的抑制剂和诱导剂。Atazanavir 也是 SARS-CoV 3CLpro 的抑制剂，IC50 为 3.49 μM。
Atazanavir Chemical Structure
CAS No. : 198904-31-3
| 规格 | 价格 | 是否有货 | 数量 |
|---|---|---|---|
| 5 mg | ￥350 | In-stock | |
| 10 mg | ￥560 | In-stock | |
| 50 mg | ￥1750 | In-stock | |
| 100 mg | ￥2450 | In-stock | |
| 200 mg | 询价 | ||
| 500 mg | 询价 |
* Please select Quantity before adding items.
Atazanavir 相关产品
•相关化合物库:
- Natural Product Library Plus
- Drug Repurposing Compound Library Plus
- FDA-Approved Drug Library Plus
- FDA-Approved Drug Library Mini
- Bioactive Compound Library Plus
- Anti-Infection Compound Library
- Membrane Transporter/Ion Channel Compound Library
- Metabolism/Protease Compound Library
- Natural Product Library
- FDA-Approved Drug Library
- Anti-Cancer Compound Library
- Antiviral Compound Library
- Peptidomimetic Library
- Anti-Aging Compound Library
- Drug Repurposing Compound Library
- Antioxidant Compound Library
- Oxygen Sensing Compound Library
- Orally Active Compound Library
- FDA Approved & Pharmacopeial Drug Library
- Alkaloids Library
- Drug-Induced Liver Injury (DILI) Compound Library
- Mitochondria-Targeted Compound Library
- Rare Diseases Drug Library
- Anti-Cancer Natural Product Library
- EMA-Approved Drug Library
- FDA-Approved Anticancer Drug Library
- Human Metabolite Library
- Non-steroidal Anti-Inflammatory Compound Library
- Heterocyclic Compound Library
- Metabolic Enzyme Compound Library
- Protease Inhibitor Library
- Membrane Protein-targeted Compound Library
- Highly Selective Inhibitors Library
- Multi-Target Compound Library
- Radioprotector Library
| 生物活性 |
Atazanavir (BMS-232632), a highly selective HIV-1 protease inhibitor, is the first protease inhibitor approved for once-daily administration[1]. Atazanavir (BMS-232632) is a substrate and inhibitor of CYP3A4, and an inhibitor and inducer of P-glycoprotein (P-gp)[2]. Atazanavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 3.49 μM[3]. |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IC50 & Target |
|
||||||||||||
| Clinical Trial |
|
||||||||||||
| 分子量 |
704.86 |
||||||||||||
| Formula |
C38H52N6O7 |
||||||||||||
| CAS 号 |
198904-31-3 |
||||||||||||
| 性状 |
固体 |
||||||||||||
| 颜色 |
White to off-white |
||||||||||||
| 中文名称 |
阿扎那韦 |
||||||||||||
| 结构分类 |
|
||||||||||||
| 初始来源 |
|
||||||||||||
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||
| 储存方式 |
|
||||||||||||
| 溶解性数据 |
In Vitro:
DMSO 中的溶解度 : 83.33 mg/mL (118.22 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响，请使用新开封的 DMSO) 配制储备液
查看完整储备液配制表
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final) This equation is commonly abbreviated as: C1V1 = C2V2
动物溶解方案计算器
请输入动物实验的基本信息：
给药剂量 mg/kg 动物的平均体重 g 每只动物的给药体积 μL 动物数量 只 由于实验过程有损耗，建议您多配一只动物的量
计算结果
工作液所需浓度 : mg/mL
|
||||||||||||
| 纯度 & 产品资料 |
纯度: 99.23%
Data Sheet (605 KB) SDS (393 KB)
COA (174 KB) HNMR (282 KB) LCMS (96 KB) OR (283 KB) 产品使用指南 (1538 KB) |
||||||||||||
| 参考文献 |
|
所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务